CVS Health Corporation (NYSE:CVS) Shares Sold by St. Johns Investment Management Company LLC

St. Johns Investment Management Company LLC trimmed its holdings in CVS Health Corporation (NYSE:CVS) by 26.2% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 9,400 shares of the pharmacy operator’s stock after selling 3,330 shares during the period. St. Johns Investment Management Company LLC’s holdings in CVS Health were worth $637,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in CVS. Hopwood Financial Services Inc. purchased a new stake in CVS Health during the 4th quarter valued at approximately $29,000. McIlrath & Eck LLC raised its stake in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 174 shares during the last quarter. Providence First Trust Co acquired a new stake in shares of CVS Health during the fourth quarter worth $42,000. Park Square Financial Group LLC purchased a new position in CVS Health in the 4th quarter valued at $43,000. Finally, PARK CIRCLE Co increased its stake in CVS Health by 42.9% in the 4th quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator’s stock valued at $45,000 after buying an additional 300 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insiders Place Their Bets

In other news, Director Guy P. Sansone purchased 1,570 shares of the firm’s stock in a transaction on Thursday, June 5th. The shares were bought at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director now directly owns 12,007 shares of the company’s stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms have recently commented on CVS. Barclays set a $79.00 target price on shares of CVS Health and gave the stock an “overweight” rating in a research note on Monday, June 2nd. Wells Fargo & Company restated an “overweight” rating and issued a $84.00 price objective (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Truist Financial lifted their price objective on CVS Health from $82.00 to $84.00 and gave the company a “buy” rating in a report on Monday, May 12th. Royal Bank Of Canada increased their target price on CVS Health from $74.00 to $81.00 and gave the stock an “outperform” rating in a research note on Monday, May 5th. Finally, Mizuho lifted their price target on CVS Health from $70.00 to $76.00 and gave the company an “outperform” rating in a research note on Wednesday, April 9th. Two analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $74.75.

CVS Health Price Performance

CVS Health stock opened at $66.93 on Tuesday. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The firm’s 50-day simple moving average is $64.88 and its 200 day simple moving average is $60.53. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $72.51. The firm has a market capitalization of $84.67 billion, a PE ratio of 15.97, a P/E/G ratio of 0.95 and a beta of 0.56.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter in the prior year, the firm earned $1.31 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. On average, equities research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.